C/O Nuvectis Pharma, Inc., 1 Bridge Plaza, Suite 275, Fort Lee, NJ
Summary
The estimated net worth of Matthew Kaplan is at least $565K dollars as of June 13, 2024. Matthew Kaplan is the Director of Nuvectis Pharma, Inc. and owns shares of Nuvectis Pharma, Inc. (NVCT) stock worth about $565K.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.